Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “High Bleeding Risks”

192 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 192 results

Not applicableLooking for participantsNCT05874674
What this trial is testing

The Safety of Nafamostat Mesylate for Patients With High Risk Bleeding Undergoing Hemodialysis: A Pilot Study

Who this might be right for
Dialysis; ComplicationsBleeding
Wonju Severance Christian Hospital 100
Post-approval studies (Phase 4)UnknownNCT02483169
What this trial is testing

PreventIon of IMT Progression in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage-IMT Study

Who this might be right for
Brain IschemiaIntracranial Hemorrhages
Asan Medical Center 800
Testing effectiveness (Phase 2)Looking for participantsNCT06819566
What this trial is testing

Prophylactic Endoscopic Variceal Ligation in Patients With High-risk Esophageal Varices Receiving Atezo/Bev for HCC

Who this might be right for
Hepatocellular CarcinomaEsophageal VarixBleeding Esophageal Varices
Asan Medical Center 44
Large-scale testing (Phase 3)Not Yet RecruitingNCT07012837
What this trial is testing

Transfusion Reduction in High-Bleeding-Risk Cardiac Surgery With Desmopressin

Who this might be right for
Adult Patients Undergoing Cardiac SurgeryHigh Bleeding RisksPlanned Elective Cardiac Surgery Using CPB
Imam Abdulrahman Bin Faisal University 112
Large-scale testing (Phase 3)Study completedNCT01623531
What this trial is testing

Prospective Double Blinded Randomized Control Study of the Use of Fibrinogen in High-Risk Cardiac Surgery

Who this might be right for
Cardiac Complication During Procedure
Nova Scotia Health Authority 62
Post-approval studies (Phase 4)Active Not RecruitingNCT03947229
What this trial is testing

Comparison of CLOpidogrel Monotherapy Versus Extended Dual-antiplatelet Therapy Beyond 12 Months After Implantation of Drug-eluting StEnts in High-risk Lesions or Patients; A-CLOSE Trial

Who this might be right for
Coronary Artery DiseaseDES
Yonsei University 3,200
Large-scale testing (Phase 3)Study completedNCT01465503
What this trial is testing

Novel Approaches in Preventing and Limiting Events III Trial (NAPLES III): Bivalirudin in High-risk Bleeding Patients

Who this might be right for
Bleeding
Clinica Mediterranea 837
Not applicableUnknownNCT01930903
What this trial is testing

PaneLux PTCA : Proposing an Alternative Treatment to patiEnts for Whom DES Implantation is Not Indicated, Thanks to Pantera LUX Drug Eluting Balloon

Who this might be right for
Coronary Artery DiseaseHigh Bleeding Risk Patients
Biotronik France 500
Not applicableStudy completedNCT03820206
What this trial is testing

The Value of Tranxemic Acid to Reduce Intraoperative Blood Loss During Elective Cesarean Sections in High Risk Women

Who this might be right for
Intraoperative Bleeding
Cairo University 160
Large-scale testing (Phase 3)Study completedNCT01675076
What this trial is testing

Strategy of Continued Versus Interrupted Novel Oral Anti-coagulant at Time of Device Surgery in Patients With Moderate to High Risk of Arterial Thromboembolic Events

Who this might be right for
Hematoma
Ottawa Heart Institute Research Corporation 663
Not applicableUnknownNCT01623180
What this trial is testing

Clinical Evaluation of the BioFreedom™ Stent

Who this might be right for
Stable AnginaIschemic Heart Disease SilentST Elevation (STEMI) and Non-ST Elevation (NSTEMI) Myocardial Infarction+2 more
Biosensors Europe SA 2,456
Not applicableStudy completedNCT03218787
What this trial is testing

XIENCE 90: A Safety Evaluation of 3-month DAPT After XIENCE Implantation for HBR Patients.

Who this might be right for
Coronary Artery Lesions
Abbott Medical Devices 2,047
Not applicableStudy completedNCT03526471
What this trial is testing

Omega™ Left Atrial Appendage (LAA) Occluder in Patients With Non-Valvular Atrial Fibrillation

Who this might be right for
Atrial Fibrillation
Vascular Innovations Co. Ltd. 20
Not applicableLooking for participantsNCT06321757
What this trial is testing

PREVAIL Paclitaxel-coated Balloon in Small Coronary Disease and High-bleeding Risk Patients

Who this might be right for
Coronary Artery Disease
Fundación EPIC 501
Not applicableNot Yet RecruitingNCT07353281
What this trial is testing

Carbetocin vs Misoprostol for Postpartum Hemorrhage Prevention

Who this might be right for
Postpartum ComplicationPostpartum Hemorrhage
Western Galilee Hospital-Nahariya 146
Not applicableEnrolling By InvitationNCT07387575
What this trial is testing

Screening in Relatives With Elevated Risk for Unruptured Intracranial Aneurysms

Who this might be right for
Intracranial AneurysmsSubarachnoid Hemorrhage, Aneurysmal
University of Novi Sad 300
Not applicableStudy completedNCT03023020
What this trial is testing

Management of High Bleeding Risk Patients Post Bioresorbable Polymer Coated Stent Implantation With an Abbreviated Versus Prolonged DAPT Regimen

Who this might be right for
High Bleeding RiskCoronary Artery DiseasePCI
ECRI bv 4,579
Post-approval studies (Phase 4)Study completedNCT04366583
What this trial is testing

Argon Plasma Coagulation vs Hemoclipping for Bleeding Peptic Ulcers

Who this might be right for
Bleeding Peptic Ulcer
Kaohsiung Veterans General Hospital. 166
Large-scale testing (Phase 3)Looking for participantsNCT05198960
What this trial is testing

AVAJAK: Apixaban/Rivaroxaban Versus Aspirin for Primary Prevention of Thrombo-embolic Complications in JAK2V617F-positive Myeloproliferative Neoplasms

Who this might be right for
Polycythemia VeraEssential ThrombocythemiaPrefibrotic/Early Primary Myelofibrosis+2 more
University Hospital, Brest 1,308
Not applicableLooking for participantsNCT06957366
What this trial is testing

Perioperative Anticoagulant Use for Surgery Evaluation -2 (PAUSE-2) Study Patients Receiving a Direct Oral Anticoagulant (DOACs-Dabigatran, Rivaroxaban, Apixaban or Edoxaban) and Needing Elective High-Bleed-Risk Surgery or an Invasive Procedure

Who this might be right for
Atrial Fibrillation (AF)VTE
McMaster University 920
Load More Results